# To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

> **NCT00152893** · PHASE2 · COMPLETED · sponsor: **Johane Allard** · enrollment: 52 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** chromium nicotinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00152893
- **Lead sponsor:** Johane Allard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152893, "To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00152893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*